Financials

News Discussions Technicals Seasonals

601089 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Beijing Winsunny Pharmaceutical Co., Ltd. engages in the research, development, production, sale of pharmaceutical preparations and medical devices. Its products include repaglinide tablets, ezetamine tablets, montelukast sodium chewable tablets, telmisartan tablets and atorvastatin calcium tablets. The company was founded on February 3, 1999 and is headquartered in Beijing, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

601089 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company